tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Massaro, 37 are a HOLD (12.8%), 241 are a BUY (83.39%), 11 are a SELL (3.81%).
Analyst Mark Massaro, currently employed at BTIG, carries an average stock price target met ratio of 53.59% that have a potential upside of 28.75% achieved within 191 days.
Mark Massaro’s has documented 554 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ADPT, Adaptive Biotechnologies Corp at 18-Dec-2024.
Analyst best performing recommendations are on HTGM (HTG MOLECULAR DIAGNOSTICS).
The best stock recommendation documented was for HTGM (HTG MOLECULAR DIAGNOSTICS) at 6/2/2015. The price target of $3060 was fulfilled within 1 day with a profit of $151.2 (5.2%) receiving and performance score of 51.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$9
$2.61 (40.85%)
$8
3 days ago
(18-Dec-2024)
3/8 (37.5%)
$2.52 (38.89%)
97
Buy
$7
$0.61 (9.55%)
$6
1 months 10 days ago
(11-Nov-2024)
6/11 (54.55%)
$0.51 (7.86%)
108
Hold
$5
$-1.39 (-21.75%)
$63
10 months 5 days ago
(16-Feb-2024)
2/3 (66.67%)
$1.15 (29.87%)
213
Hold
$10
$3.61 (56.49%)
$13
1 years 1 months 27 days ago
(24-Oct-2023)
1/6 (16.67%)
$5.31 (113.22%)
5
Sell
$7
$0.61 (9.55%)
$8
1 years 10 months 6 days ago
(15-Feb-2023)
2/2 (100%)
$-3.03 (-30.21%)
50
Which stock is Mark Massaro is most bullish on?
Which stock is Mark Massaro is most reserved on?
What Year was the first public recommendation made by Mark Massaro?
